Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C

Kagawa, T., & Keeffe, E. B. (2010). Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C. Hepatitis Research and Treatment, 2010(), 104-112. https://doi.org/10.1155/2010/562578
Jagiello, J. Z., Simon, M. P., Simon, K., & Warwas, M. (2012). Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report. Mediators of Inflammation, 2012(), 561-570-162. https://doi.org/10.1155/2012/762863
Caruso, C., Candore, G., Cigna, D., Tripi, S., Gaetano, G. D., Migneco, G., Montalto, G., Ruggier, I., & Notarbartolo, A. (1994). Serum levels of soluble IL-2R, CD4 and CD8 in chronic active HCV positive hepatitis. Mediators of Inflammation, 1994(), 185-187. https://doi.org/10.1155/S0962935194000256
Tsan, Y. T. (2013). Statins and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2013.02033
Poovorawan, K., Tangkijvanich, P., Chirathaworn, C., Wisedopas, N., Treeprasertsuk, S., Komolmit, P., & Poovorawan, Y. (2013). Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection. Hepatitis Research and Treatment, 2013(), 80-86. https://doi.org/10.1155/2013/757246